Видео ютуба по тегу Hr-Positive

Гормон-рецептор-положительный (HR+) рак молочной железы: варианты лечения
Гормон-рецептор-положительный (HR+) рак молочной железы: варианты лечения
Upfront Treatment of HR-Positive Metastatic Breast Cancer
Upfront Treatment of HR-Positive Metastatic Breast Cancer
Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer
Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast Cancer
ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne
ASCO 2023 Expert Report in HR positive, HER2 negative breast cancer by Catherine Harper-Wynne
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Staying Up to Date on the Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer
Staying Up to Date on the Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer
What's the Best Diet for Hormone Receptor-Positive Breast Cancer? The Ultimate Guide for HR+
What's the Best Diet for Hormone Receptor-Positive Breast Cancer? The Ultimate Guide for HR+
Treatment Sequencing Strategies in HR-Positive, HER2-Negative Breast Cancer
Treatment Sequencing Strategies in HR-Positive, HER2-Negative Breast Cancer
What is Hormone Receptor-Positive Breast Cancer? HR+, ER+, and PR+ Explained
What is Hormone Receptor-Positive Breast Cancer? HR+, ER+, and PR+ Explained
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metas...
Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metas...
Quality of Life for Women with HR-Positive Breast Cancer
Quality of Life for Women with HR-Positive Breast Cancer
Updates in HR-Positive mBCa
Updates in HR-Positive mBCa
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
Optimizing adjuvant therapy: chemotherapy necessity in HR-positive breast cancer
Optimizing adjuvant therapy: chemotherapy necessity in HR-positive breast cancer
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
Advancing the Care of Patients With High-Risk HR-Positive/HER2-Negative Early Breast Cancer
Optimizing the Management of Endocrine-Resistant HR-Positive Metastatic Breast Cancer
Optimizing the Management of Endocrine-Resistant HR-Positive Metastatic Breast Cancer
Advanced HR-Positive Breast Cancer: Oral SERDs in Focus
Advanced HR-Positive Breast Cancer: Oral SERDs in Focus
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Sympo...
Endocrine-Based Therapy for HR-Positive Breast Cancer — Proceedings from a San Antonio 2025 Sympo...
Role of endocrine therapy in early-stage HR-positive breast cancer
Role of endocrine therapy in early-stage HR-positive breast cancer